{"id":"W2163934471","doi":"10.1016/j.juro.2012.02.911","title":"821 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA TRIAL OF A CA <sup>2+</sup> CHANNEL α2Δ LIGAND, PD-0299685, FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Interstitial cystitis; Bladder Pain Syndrome; Medicine; Placebo; Tolerability; Internal medicine; Urinary system; Pathology; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001403976,0.001518646,0.001938015,0.0004189773,0.000678895,0.001271307,0.0007570256,0.002540415,0.02113357],"category_scores_gemma":[0.001776533,0.0007620099,0.001700084,0.0003011671,0.0008263438,0.0008266703,0.0002923874,0.002355365,0.002417017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005191643,"about_ca_system_score_gemma":0.001356342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001124325,"about_ca_topic_score_gemma":0.002590141,"domain_scores_codex":[0.9995257,0.000232944,0.00003937034,0.00007596668,0.00005874232,0.00006733902],"domain_scores_gemma":[0.9993731,0.000188092,0.0001407086,0.00004947632,0.00008289012,0.0001657315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9655268,0.008411399,0.0002514034,0.001224524,0.0008035243,0.00004062161,0.00002909001,0.0001359634,0.004025198,0.0001597301,0.004958481,0.01443329],"study_design_scores_gemma":[0.9740877,0.02352771,0.0004859946,0.0000464236,0.0002115923,0.00001173914,0.000008215457,0.0001011027,0.0002295201,0.00005509171,0.001227578,0.000007268657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8880882,0.02929859,0.002323628,0.005734551,0.004649547,0.03296421,0.009737879,0.0006181396,0.0265852],"genre_scores_gemma":[0.8896238,0.01781595,0.005547466,0.0104061,0.002541855,0.02234619,0.007790994,0.0001095219,0.04381821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02113357,"threshold_uncertainty_score":0.07069886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04862218633408647,"score_gpt":0.3479016185386679,"score_spread":0.2992794322045814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}